It has been shown that radiolabeled MX35-based antibodies, as well as their derivatives, when administered in vivo to humans or animals, predominantly accumulate in tumor foci and do not linger in healthy tissues and organs, even if they express NaPi2b on the cell surface [30,33]. Here, SLC34A2 is linked to neoplasm.